Daily Archives: 04/10/2012


Tagged , , ,

Check out the first set photo of Tarantino’s ‘Django Unchained’

Check out the first set photo of Tarantino’s ‘Django Unchained’ And it’s Christoph Waltz, all heeled and ready to kick some ass. Oh lord I can’t wait. Via

And it’s Christoph Waltz, all heeled and ready to kick some ass. Oh lord I can’t wait.


Tagged , , , , , , ,

Watch Arthur C. Clarke predict personal computers and the internet in 1974

The minute and a half clip is from Australia’s ABC network, and in it Clarke not only predicts that by 2001 every home will have a compact computer console, but that they’ll all be connected letting users do everything from remote banking, to buying theater tickets. He even predicts how computers will eventually let us telecommute, and as Clarke always was, is optimistic that these new technologies will enrich humanity instead of isolating us.


Tagged , , , , ,

Peanut butter and jelly vodka should be disgusting

All the 13 year old girls who still drink vodka will love to mix this with whipped cream vodka and scream annoying shit.

Van Gogh is proud to introduce their own take on the classic PB&J, transforming its timeless flavor into a delightfully smooth peanut butter and raspberry jelly flavored vodka. Master Distiller Tim Vos selected raspberry flavored jelly after taste-testing peanut butter sandwiches matched with various jellies. While the fragrance is predominately of peanuts, it is complimented by the fresh fruit aroma of the raspberry. On the tongue, the roles are reversed and the raspberry flavor is more of the focal point, giving it a velvety texture with a hint of vanilla on the side.

Product link


Tagged , , , ,

Get out those cigarettes and light ’em up, a universal cancer vaccine has been developed

For decades, the holy grail of cancer research has been a universal cancer vaccine, one that would target a wide variety of different types of cancers, caused by myriad causes. Brain cancer is different than breast cancer is different than lung cancer is different than liver cancer, but scientists have finally developed a cancer drug that targets a molecule found in 90% of all cancers.

Preliminary results from early clinical trials have shown the vaccine can trigger an immune response in patients and reduce levels of disease.

The scientists behind the vaccine now hope to conduct larger trials in patients to prove it can be effective against a range of different cancers.

They believe it could be used to combat small tumours if they are detected early enough or to help prevent the return and spread of disease in patients who have undergone other forms of treatment such as surgery.

Cancer cells usually evade patient’s immune systems because they are not recognised as being a threat. While the immune system usually attacks foreign cells such as bacteria, tumours are formed of the patient’s own cells that have malfunctioned.

Scientists have, however, found that a molecule called MUC1, which is found in high amounts on the surface of cancer cells, can be used to help the immune system detect tumours.

The new vaccine, developed by drug company Vaxil Biotheraputics along with researchers at Tel Aviv University, uses a small section of the molecule to prime the immune system so that it can identify and destroy cancer cells.

A statement from Vaxil Biotheraputics said: “ImMucin generated a robust and specific immune response in all patients which was observed after only 2-4 doses of the vaccine out of a maximum of 12 doses.

“In some of the patients, preliminary signs of clinical efficacy were observed.”

The results are still to be formally published but if further trials prove to be successful the vaccine could be available within six years.

As a therapeutic vaccine it is designed to be given to patients who are already suffering from cancer to help their bodies fight off the disease rather than to prevent disease in the first place.

Cancer cells contain high levels of MUC1 as it is thought to be involved helping tumours grow. Healthy human cells also contain MUC1, but have levels that are too low to trigger the immune system after vaccination.


Tagged , , , , , ,

Is Joseph Gordon Levitt playing the joker in the new Batman movie?

There hasn’t been any good Dark Knight Rises speculation going on for a while, so I’m going to resurrect one that hasn’t been seen in about a year— Joseph Gordon Levitt could be playing the Joker, not some beat cop and Christopher Nolan used that as a red herring.

First, just look at that comparison photo. Sure, Ledger had a slightly bigger build than Levitt does, but in the slightly oversized Joker costume and the way he hunched over, his body shape was completely lost. The important part here is the face. Very, very similar.

Here’s an artistic interpretation I dug up for further comparison:

Second… JGL was known to be in talks with Nolan for a “major role” for a while, and had worked with Nolan before, and after months of speculation on who Levitt would play— many people were speculating the Riddler or Robin— he gets cast as a cop? Nooooo.

The character Levitt is listed as playing is “John Blake”, but if you take the first two and last two letters from that name, you get “Joke”. Hmmmm?

Despite some leaks, the last fifteen minutes of the film are crucial. So crucial, so secret, that only Nolan and a couple actors directly involved even had access to those script pages until right before shooting that final sequence. Again, many people have speculated that Levitt might end up playing Robin, and that this last sequence might be a lead-in to a Robin/Nightwing movie. I think that would be pretty cool, but I tend to believe Nolan at this point when he says that there is no place for Robin in his Batman movies, and there would have to be a lot more lead up than the last 15 minutes (I suppose) to introduce Robin.

But the Joker? He’s had his own movie, he doesn’t need a lead-in. All he needs to do is show up.


Tagged , , , , , , ,
%d bloggers like this: